What is Sarepta Therapeutics, Inc.'s price / sales?

Sarepta Therapeutics, Inc. (SRPT) reported price / sales of 1× in Q1 2026.

What is the long-term trend for Sarepta Therapeutics, Inc.'s price / sales?

Over 4 years (2020 to 2025), Sarepta Therapeutics, Inc.'s price / sales has grown at a -55.0% compound annual growth rate (CAGR), from 25.1× to 1×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Sarepta Therapeutics, Inc. SRPT Price / sales

Price / sales at other companies

PfizerPFE

2.5×+0.2×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

BioMarin PharmaceuticalsBMRN

3.4×-1.2×

PTC TherapeuticsPTCT

6.8×+4.6×

InsmedINSM

43×+6.8×

Capricor TherapeuticsCAPR

29.6×+6.5×

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.82B-63.1%

Enterprise value$1.56B-67.2%

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Calculated from Sarepta Therapeutics, Inc.’s reported figures.

market cap/total revenue=1×

Based on the most recent quarter.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s price / sales?: Sarepta Therapeutics, Inc. (SRPT) reported price / sales of 1× in Q1 2026.
What is the long-term trend for Sarepta Therapeutics, Inc.'s price / sales?: Over 4 years (2020 to 2025), Sarepta Therapeutics, Inc.'s price / sales has grown at a -55.0% compound annual growth rate (CAGR), from 25.1× to 1×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.